Smith and Nephew Annual Profit Rises 15.5 Percent for 2025
The British medical products maker reported a trading profit of 1.21 billion dollars for 2025. This growth follows successful cost saving measures and turnaround plans.
Smith & Nephew plc, a prominent medical technology manufacturer based in the United Kingdom, has reported a 15.5% increase in its annual trading profit. The company announced on Monday that its profit for the fiscal year ending December 2025 reached $1.21 billion, up from $1.05 billion in the previous year. This growth is attributed to the successful implementation of turnaround plans that delivered significant cost savings and boosted performance across all business divisions. By streamlining operations and focusing on divisional growth, the company has strengthened its financial position and continues to build on its strategic objectives within the global healthcare market.
